Early Access

10-QPeriod: Q2 FY2009

METLIFE INC Quarterly Report for Q2 Ended Jun 30, 2009

Filed August 4, 2009For Securities:METMET-PEMET-PFMET-PA

Summary

MetLife Inc. reported a net loss of $1.433 billion, or $1.74 per diluted share, for the second quarter of 2009, a significant decline from the $915 million net income ($1.26 per diluted share) reported in the same period of 2008. This was primarily driven by substantial net investment losses of $3.829 billion, largely due to increased losses on derivatives and impairments across various asset classes, reflecting ongoing market volatility. Premiums, fees, and other revenues saw a modest increase, but were outpaced by the investment losses and higher policyholder benefits. The company maintained a strong liquidity position with $13.2 billion in cash and cash equivalents, though it is holding higher than usual levels of short-term investments to navigate market uncertainty. Management highlighted ongoing cost reduction initiatives and a focus on disciplined underwriting and hedging strategies to manage the challenging economic environment.

Financial Statements
Beta
Revenue$8.26B
Operating Expenses$2.03B
Operating Income-$2.04B
Interest Expense$256.00M
Net Income-$1.40B
EPS (Basic)$-1.74
EPS (Diluted)$-1.74
Shares Outstanding (Basic)821.59M
Shares Outstanding (Diluted)821.59M

Key Highlights

  • 1Net loss of $1.433 billion for Q2 2009, down from a net income of $915 million in Q2 2008.
  • 2Diluted loss per share of $1.74 in Q2 2009, compared to diluted income per share of $1.26 in Q2 2008.
  • 3Total revenues decreased to $8.266 billion in Q2 2009 from $12.049 billion in Q2 2008, primarily due to lower net investment income and increased net investment losses.
  • 4Net investment losses significantly increased to $3.829 billion in Q2 2009, driven by derivatives and impairments, compared to $357 million in Q2 2008.
  • 5Policyholder benefits and claims increased to $6.946 billion in Q2 2009 from $6.579 billion in Q2 2008.
  • 6Other expenses decreased to $2.031 billion in Q2 2009 from $2.607 billion in Q2 2008, reflecting cost reduction initiatives.
  • 7Cash and cash equivalents stood at $13.213 billion at June 30, 2009, demonstrating continued liquidity.

Frequently Asked Questions